Hamilton Lane Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-448
| Closed | -$79.2K | – | 64 |
|
|
2023
Q1 | $79.2K | Hold |
448
| – | – | 0.03% | 57 |
|
|
2022
Q4 | $173K | Hold |
448
| – | – | 0.06% | 58 |
|
|
2022
Q3 | $151K | Hold |
448
| – | – | 0.06% | 61 |
|
|
2022
Q2 | $147K | Hold |
448
| – | – | 0.06% | 64 |
|
|
2022
Q1 | $196K | Hold |
448
| – | – | 0.04% | 72 |
|
|
2021
Q4 | $196K | Hold |
448
| – | – | 0.03% | 83 |
|
|
2021
Q3 | $249K | Hold |
448
| – | – | 0.04% | 69 |
|
|
2021
Q2 | $230K | Buy |
+448
| New | +$230K | 0.07% | 73 |
|
|
2015
Q2 | – | Sell |
-1,659
| Closed | -$600K | – | 73 |
|
|
2015
Q1 | $600K | Sell |
1,659
-555
| -25% | -$201K | 0.27% | 35 |
|
|
2014
Q4 | $795K | Sell |
2,214
-278
| -11% | -$99.8K | 0.3% | 34 |
|
|
2014
Q3 | $753K | Buy |
+2,492
| New | +$753K | 0.25% | 37 |
|